Twenty years on: the impact of fragments on drug discovery

Erlanson, Daniel A., Fesik, Stephen W., Hubbard, Roderick E., Jahnke, Wolfgang, Jhoti, Harren·2016·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2016.109

Cited by (1,000)

Items 501–600 of 1,000

  1. QM assisted ML for 19F NMR chemical shift prediction
    Patrick Penner, Anna Vulpetti · 2023 · Journal of Computer-Aided Molecular Design
  2. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning
    Hao Zhang, Jinchao Huang, Junjie Xie, Weifeng Huang, Yuedong Yang, Mingyuan Xu, Jinping Lei, Hongming Chen · 2024 · Journal of Chemical Information and Modeling
  3. Review of the impact of fragment-based drug design on PROTAC degrader discovery
    Peiqi Chen, Qiang Li, Xiaoguang Lei · 2024 · TrAC Trends in Analytical Chemistry
  4. Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening
    Rohan Chandraghatgi, Hai‐Feng Ji, GAIL L. ROSEN, Bahrad Ali Sokhansanj · 2024 · Journal of Chemical Information and Modeling
  5. Novel drug discovery approaches for MMP-13 inhibitors in the treatment of osteoarthritis
    Yi Wang · 2024 · Bioorganic & Medicinal Chemistry Letters
  6. Reinforcement learning-based generative artificial intelligence for novel pesticide design
    Ruoqi Yang, Biao Li, Jin Dong, Zhuo-Mei Cai, Hong‐Yan Lin, Fan Wang, Guang‐Fu Yang · 2025 · Journal of Advanced Research
  7. Toward routine utilisation of native mass spectrometry as an enabler of contemporary drug development
    Louise M. Sternicki, Sally‐Ann Poulsen · 2025 · RSC Medicinal Chemistry
  8. Efficient Synthesis of 1,4-Thiazepanones and 1,4-Thiazepanes as 3D Fragments for Screening Libraries
    Anil K. Pandey, Steven E. Kirberger, Jorden A. Johnson, Jennifer R. Kimbrough, Danika K. D. Partridge, William C. K. Pomerantz · 2020 · Organic Letters
  9. Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors
    Lauren D. Hagler, Long M. Luu, Marco Tonelli, JuYeon Lee, Samuel M. Hayes, Sarah E. Bonson, J. Ignacio Vergara, Samuel E. Butcher, Steven C. Zimmerman · 2020 · Biochemistry
  10. Engineered protein-small molecule conjugates empower selective enzyme inhibition
    Andrew K. Lewis, Abbigael Harthorn, Sadie M. Johnson, Roy R. Lobb, Benjamin J. Hackel · 2021 · Cell chemical biology
  11. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library
    Xiaohao Lan, Yueli Zhang, Xiaoying Jia, Siqi Dong, Yang Liu, Mengmeng Zhang, Jiao Guo, Junyuan Cao, Yu Guo, Gengfu Xiao et al. · 2021 · Antiviral Research
  12. Biomarkers
    Jorge Manzanares, Francisco Sala, María S. García‐Gutiérrez, Francisco Navarrete Rueda · 2021 · Elsevier eBooks
  13. Efficient Screening of Target‐Specific Selected Compounds in Mixtures by 19F NMR Binding Assay with Predicted 19F NMR Chemical Shifts
    Anna Vulpetti, Andreas Lingel, Claudio Dalvit, Nikolaus Schiering, Lukas Oberer, Christelle Henry, Yipin Lu · 2022 · ChemMedChem
  14. 19 F chemical library and 19 F-NMR for a weakly bound complex structure
    Shoko Shinya, Ritsuko Katahira, Kyoko Furuita, Toshihiko Sugiki, Young‐Ho Lee, Yoshikazu Hattori, Kohei Takeshita, Atsushi Nakagawa, Aoi Kokago, Ken‐ichi Akagi et al. · 2022 · RSC Medicinal Chemistry
  15. Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers
    Miriam Schöpel, Oleksandr Shkura, Jana Seidel, Klaus Kock, Xueyin Zhong, Stefanie Löffek, Iris Helfrich, Hagen S. Bachmann, Jürgen Scherkenbeck, Christian Herrmann et al. · 2018 · International Journal of Molecular Sciences
  16. Extending the Detection Limit in Fragment Screening of Proteins Using Reverse Micelle Encapsulation
    Brian Fuglestad, Nicole E. Kerstetter, Sabrina Bédard, A. Joshua Wand · 2019 · ACS Chemical Biology
  17. Selection of Promising Novel Fragment Sized S. aureus SrtA Noncovalent Inhibitors Based on QSAR and Docking Modeling Studies
    Dmitry Alexandrovich Shulga, Konstantin V. Kudryavtsev · 2021 · Molecules
  18. Advances with weak affinity chromatography for fragment screening
    Fotios N. Tsopelas, Anna Tsantili‐Kakoulidou · 2019 · Expert Opinion on Drug Discovery
  19. Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.
    Xiaojie Huang, Junsong Guo, Qi Liu, Qiong Gu, Jun Xu, Huihao Zhou · 2018 · PubMed Central
  20. Chemical genetics and strigolactone perception
    Shelley Lumba, Michael Bunsick, Peter McCourt · 2017 · F1000Research
  21. An asymmetric structure of bacterial TrpRS supports the half-of-the-sites catalytic mechanism and facilitates antimicrobial screening
    Manli Xiang, Kaijiang Xia, Bingyi Chen, Zhiteng Luo, Ying Yu, Lili Jiang, Huihao Zhou · 2023 · Nucleic Acids Research
  22. Rapid Elaboration of Fragments into Leads Applied to Bromodomain-3 Extra-Terminal Domain
    Luke A. Adams, Lorna E. Wilkinson‐White, Menachem J. Gunzburg, Stephen J. Headey, Biswaranjan Mohanty, Martin J. Scanlon, Ben Capuano, Joel P. Mackay, B.C. Doak · 2023 · Journal of Medicinal Chemistry
  23. Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection
    Xavier Jalencas, Hannes Berg, Ludvik Olai Espeland, Sridhar Sreeramulu, Franziska Kinnen, Christian Paolo Richter, Charis Georgiou, Vladyslav Yadrykhins'ky, Edgar Specker, Kristaps Jaudzems et al. · 2024 · RSC Medicinal Chemistry
  24. A Novel NMR-Based Protocol to Screen Ultralow Molecular Weight Fragments
    Annagiulia Favaro, Mattia Sturlese · 2024 · Journal of Medicinal Chemistry
  25. Advanced technologies for screening and identifying covalent inhibitors
    Yaolin Guo, Shuai Wen, Aiping Tong, Yuxi Wang · 2024 · TrAC Trends in Analytical Chemistry
  26. A Continuous Flow Strategy for the Facile Synthesis and Elaboration of Semi‐Saturated Heterobicyclic Fragments
    Nicola Luise, Eleanor W. Wyatt, Gary J. Tarver, Paul Graham Wyatt · 2018 · European Journal of Organic Chemistry
  27. Genetic and structural validation of phosphomannomutase as a cell wall target in Aspergillus fumigatus
    Yuanwei Zhang, Wenxia Fang, Olawale G. Raimi, Deborah E. A. Lockhart, Andrew T. Ferenbach, Ling Lü, Daan M. F. van Aalten · 2021 · Molecular Microbiology
  28. Structure-based design of a novel inhibitor of the ZIKA virus NS2B/NS3 protease
    Yanchao Xiong, Fei Cheng, Junyi Zhang, Haixia Su, Hangchen Hu, Yi Zou, Minjun Li, Yechun Xu · 2022 · Bioorganic Chemistry
  29. Exploration of Chemical Space Guided by PixelCNN for Fragment-Based De Novo Drug Discovery
    Satoshi F. Noguchi, Junya Inoue · 2022 · Journal of Chemical Information and Modeling
  30. Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinates
    Simon P. Jones, James D. Firth, Mary C. Wheldon, Masakazu Atobe, Roderick E. Hubbard, David C. Blakemore, Claudia De Fusco, Simon C. C. Lucas, Stephen D. Roughley, Lewis R. Vidler et al. · 2022 · RSC Medicinal Chemistry
  31. Structure-guided engineering of TGF-βs for the development of novel inhibitors and probing mechanism
    Andrew P. Hinck · 2018 · Bioorganic & Medicinal Chemistry
  32. Shape-Based Descriptors for Efficient Structure-Based Fragment Growing
    Patrick Penner, Virginie Y. Martiny, Arnaud Gohier, Marcus Gastreich, Pierre Ducrot, David Brown, Matthias Rarey · 2020 · Journal of Chemical Information and Modeling
  33. Cosolvent Simulations with Fragment-Bound Proteins Identify Hot Spots to Direct Lead Growth
    Pancham Lal Gupta, Heather A. Carlson · 2022 · Journal of Chemical Theory and Computation
  34. Plant natural fragments, an innovative approach for drug discovery
    Bruno David, Antonio Grondin, Philippe Schambel, Marc Vitorino, Denis Zeyer · 2019 · Phytochemistry Reviews
  35. The Nature of Ligand Efficiency
    Peter J. Kenny · 2018 · ChemRxiv
  36. Stabilization of Native Protein–Protein Interactions with Molecular Glues: A 14-3-3 Case Study
    Markella Konstantinidou, Johanna M. Virta, Michelle R. Arkin · 2025 · Accounts of Chemical Research
  37. Analyzing Interactions with the Fragment Molecular Orbital Method
    Dmitri G. Fedorov · 2020 · Methods in molecular biology
  38. Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97
    Sebastian Bothe, Petra Hänzelmann, Stephan Böhler, Josef Kehrein, Markus Zehe, Christoph Wiedemann, Ute A. Hellmich, Ruth Brenk, Hermann Schindelin, Christoph Sotriffer · 2022 · Communications Chemistry
  39. A guide to bullvalene stereodynamics
    Robert A. Ives, William Maturi, Matthew T. Gill, Conor D. Rankine, Paul R. McGonigal · 2024 · Chemical Science
  40. Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery
    Qingxin Li, CongBao Kang · 2024 · Molecules
  41. Medicinal Chemistry behind Capivasertib Discovery: Seventh Magic Bullet of the Fragment-based Drug Design Approved for Oncology
    Leandro Marcos Santos, Leonardo Pereira de Araújo, Lorena Falleiros, Chiara Mariano, Walter Filgueira de Azevedo, Nelson José Freitas da Silveira · 2025 · Current Medicinal Chemistry
  42. Fragment‐Based Drug Discovery of Novel High‐affinity, Selective, and Anti‐inflammatory Inhibitors of the Keap1‐Nrf2 Protein‐Protein Interaction
    Chun‐Yu Lin, Dilip Narayanan, Marilia Barreca, Cecilie Poulsen, Leandro Silva da Costa, Xiangrong Chen, Kendall G. Wichman, Cherisse A. Charley, Jaslin L. Lindsay, Mahya Dezfouli et al. · 2025 · Angewandte Chemie International Edition
  43. The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design
    Shaun D. Rawson, Martin J. McPhillie, Rachel M. Johnson, Colin W. G. Fishwick, Stephen P. Muench · 2017 · Acta Crystallographica Section D Structural Biology
  44. Best Practices for Design and Characterization of Covalent Chemical Probes
    Ronen Gabizon, Efrat Resnick, Nir London · 2020 · Royal Society of Chemistry eBooks
  45. Fragment dissolved molecular dynamics: a systematic and efficient method to locate binding sites
    Cristian Privat, José M. Granadino‐Roldán, Jordi Bonet, María Santos Tomás Belenguer, Juan Jesús Pérez, J. Rubio · 2020 · Physical Chemistry Chemical Physics
  46. Dual Bcl-XL /Bcl-2 inhibitors discovered from DNA-encoded libraries using a fragment pairing strategy
    Jean‐Pierre Daguer, Arthur Gonse, Yevhenii Shchukin, Lluc Farrera Soler, Sofía Barluenga, Nicolas Winssinger · 2021 · Bioorganic & Medicinal Chemistry
  47. A Network Enhancement Method to Identify Spurious Drug-Drug Interactions
    Huan Wang, Ziwen Cui, Yinguang Yang, Baijing Wang, Lida Zhu, Wen Zhang · 2024 · IEEE Transactions on Computational Biology and Bioinformatics
  48. Time-series analysis of rhenium(I) organometallic covalent binding to a model protein for drug development
    Frederick J. F. Jacobs, John Richard Helliwell, Alice Brink · 2024 · IUCrJ
  49. What is the Future for Fragment-Based Drug Discovery?
    György Miklós Keserű, Michael M. Hann · 2017 · Future Medicinal Chemistry
  50. Fragment-Based Structural Optimization of a Natural Product Itampolin A as a p38α Inhibitor for Lung Cancer
    Jingwei Liang, Mingyang Wang, Shan Wang, Xinyang Li, Fan‐hao Meng · 2019 · Marine Drugs
  51. Substituted 1-methyl-4-phenylpyrrolidin-2-ones – Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors
    J.P. Hilton-Proctor, Olga V. Ilyichova, Zhaohua Zheng, Ian G. Jennings, Ricky W. Johnstone, Jake Shortt, Simon J. Mountford, Martin J. Scanlon, Philip Evan Thompson · 2020 · European Journal of Medicinal Chemistry
  52. Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery
    Rushing, Blake, Rohlik, Denise, Roy, Sourav, Skaff, D., Garcia, Brandon · 2020 · Molecules
  53. Fast Mek1 Hit Identification with TRIC Technology Correlates Well with Other Biophysical Methods
    Semir Jeridi, Alexey Rak, Amit J. Gupta, Pierre Soule · 2021 · SLAS DISCOVERY
  54. Exploring the kinase-inhibitor fragment interaction space facilitates the discovery of kinase inhibitor overcoming resistance by mutations
    Zhi-Zheng Wang, Mingshu Wang, Fan Wang, Xing-Xing Shi, Wei Huang, Ge‐Fei Hao, Guang‐Fu Yang · 2022 · Briefings in Bioinformatics
  55. Metabolite-protein interactions: Native mass spectrometry and collision induced affinity selection mass spectrometry in natural product screening
    Yushu Gu, Miaomiao Liu, Ronald J. Quinn · 2022 · Frontiers in Analytical Science
  56. The impact of structural biology in medicine illustrated with four case studies
    Tiancen Hu, Elizabeth R. Sprague, Michelle Fodor, Travis Stams, Kirk Clark, Sandra W. Cowan‐Jacob · 2017 · Journal of Molecular Medicine
  57. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery
    Hiroyuki Hanzawa, Takashi Shimada, Mizuki Takahashi, Hideo Kohka Takahashi · 2020 · Journal of Biomolecular NMR
  58. Fragment-based drug discovery of small molecule ligands for the human chemokine CCL28
    Angela L. Zhou, Davin R. Jensen, Francis C. Peterson, Monica A. Thomas, Roman R. Schlimgen, Michael B. Dwinell, Brian C. Smith, Brian F. Volkman · 2023 · SLAS DISCOVERY
  59. Deconstructing allostery by computational assessment of the binding determinants of allosteric PTP1B modulators
    Adele Hardie, Benjamin P. Cossins, Silvia Lovera, Julien Michel · 2023 · Communications Chemistry
  60. Position Matters: Effect of Nitro Group in Chalcones on Biological Activities and Correlation via Molecular Docking
    Alam Yair Hidalgo, Nancy Romero‐Ceronio, Carlos Ernesto Lobato-García, Maribel Lucila Herrera-Ruiz, Romario Vázquez-Cancino, Omar Aristeo Peña-Morán, Miguel Angel Vilchis‐Reyes, Ammy Joana Gallegos‐García, Eric Jaziel Medrano‐Sánchez, Oswaldo Hernández‐Abreu et al. · 2024 · Scientia Pharmaceutica
  61. Revealing protein structures: crystallization of protein‐ligand complexes – co‐crystallization and crystal soaking
    Barbora Kaščáková, Anna Koutská, Michaela Burdová, Petra Havlíčková, Ivana Kutá Smatanová · 2024 · FEBS Open Bio
  62. Machine learning potential model for accelerating quantum chemistry‐driven property prediction and molecular design
    Guoxin Wu, Yujing Zhao, Lei Zhang, Jian Du, Qingwei Meng, Qilei Liu · 2025 · AIChE Journal
  63. In-silico 3D molecular editing through physics-informed and preference-aligned generative foundation models
    Xiaohan Lin, Yijie Xia, Y. G. Li, Yupeng Huang, Shuo Liu, Jun Zhang, Yi Qin Gao · 2025 · Nature Communications
  64. Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties
    Emeline Charnelle, Alexandre Gobert, Romain Marteau, Maëla Pautric, Nicolas Renault, Aurélie Jonneaux, Darius Mazhari Dorooee, Amélie Laversin, Jean-Christophe Devedjian, Patricia Melnyk et al. · 2025 · Journal of Medicinal Chemistry
  65. High‐Throughput Synthesis and Screening of a Cyanimide Library Identifies Selective Inhibitors of ISG15‐Specific Protease mUSP18
    Raymond Kooij, Vito Pol, Jin Gan, Bjorn R. van Doodewaerd, Ayşegül Sapmaz, Marta Campos Alonso, Günter Fritz, Klaus‐Peter Knobeloch, Paul P. Geurink · 2025 · Angewandte Chemie International Edition
  66. What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
    Paul D. Leeson · 2026 · Journal of Medicinal Chemistry
  67. Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
    Christopher A. Lipinski, Andrew G. Reaume · 2022 · Frontiers in Pharmacology
  68. FastGrow: on-the-fly growing and its application to DYRK1A
    Patrick Penner, Virginie Y. Martiny, Louis Bellmann, Florian Flachsenberg, Marcus Gastreich, Isabelle Théret, Christophe Meyer, Matthias Rarey · 2022 · Journal of Computer-Aided Molecular Design
  69. Discovery of Five SOS2 Fragment Hits with Binding Modes Determined by SOS2 X-Ray Cocrystallography
    Christopher R. Smith, Dan Chen, James G. Christensen, René Coulombe, James Féthière, Robin J. Gunn, Johan G. Hollander, Benjamin Jones, John M. Ketcham, Shilpi Khare et al. · 2023 · Journal of Medicinal Chemistry
  70. NMR screening and studies of target – ligand interactions
    Vladimir I. Polshakov, E. A. Batuev, Alexey B. Mantsyzov · 2018 · Russian Chemical Reviews
  71. Binding patterns and structure–activity relationship of CDK8 inhibitors
    Duo Ma, Xing Chen, Xiaobao Shen, Liang Sheng, Xin Hua Liu · 2020 · Bioorganic Chemistry
  72. A Modular Approach to Dibenzo‐fused ϵ‐Lactams: Palladium‐Catalyzed Bridging‐C−H Activation
    Yinghua Yu, Liyao Ma, Jiajin Xia, Luoting Xin, Lei Zhu, Xueliang Huang · 2020 · Angewandte Chemie
  73. Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS‐CoV‐2
    Yassine Rabhi, Makrem Mrabet, Farhat Fnaiech · 2021 · BioMed Research International
  74. Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
    J. Wollenhaupt, Tatjana Barthel, G.M.A. Lima, A. Metz, Dirk Wallacher, Elmir Jagudin, Franziska U. Huschmann, Thomas Hauß, Christian G. Feiler, Martin Gerlach et al. · 2021 · Journal of Visualized Experiments
  75. C(sp 3 )–H arylation to construct all- syn cyclobutane-based heterobicyclic systems: a novel fragment collection
    Thomas J. Osberger, Sarah L. Kidd, Thomas A. King, David R. Spring · 2020 · Chemical Communications
  76. Identification of new building blocks by fragment screening for discovering GyrB inhibitors
    Ying Yu, Junsong Guo, Zhengjun Cai, Yingchen Ju, Jun Xu, Qiong Gu, Huihao Zhou · 2021 · Bioorganic Chemistry
  77. Developing Polo-like Kinase 1 Inhibitors
    Xu‐Feng Huang, Zhouling Xie, Chenzhong Liao · 2020 · Future Medicinal Chemistry
  78. Open Science Discovery of Oral Non-Covalent SARS-CoV-2 Main Protease Inhibitors
    John D. Chodera, Alpha A. Lee, Nir London, F. von Delft · 2021
  79. From Patterns to Pills: How Informatics Is Shaping Medicinal Chemistry
    Alexander Trachtenberg, Barak Akabayov · 2025 · Pharmaceutics
  80. A bottom-up approach to find lead compounds in expansive chemical spaces
    Álvaro Serrano‐Morrás, Andrea Bertran‐Mostazo, Marina Miñarro-Lleonar, Arnau Comajuncosa-Creus, Adrià Cabello, Carme Labranya, Carmen Escudero, Tian V. Tian, Inna Khutorianska, Dmytro S. Radchenko et al. · 2025 · Communications Chemistry
  81. The covalent docking software landscape: features and applications in drug design
    Natesh Singh, Philippe Vayer, Bruno O. Villoutreix · 2025 · Briefings in Bioinformatics
  82. Synthesis of sp 3 -rich heterocyclic frameworks by a divergent synthesis strategy
    Kim T. Mortensen, Denedy S. Y. Wong, Thomas A. King, Hannah F. Sore, David R. Spring · 2023 · Organic & Biomolecular Chemistry
  83. The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature Review
    Arindam Malakar, Vivek Kumar, Priya Yadav, Vishal Bhardwaj, Chuimee Gogoi Barua, Gourika Bhardwaj · 2023 · Cureus
  84. The allure of targets for novel drugs
    Colin J. Suckling · 2023 · RSC Medicinal Chemistry
  85. Optimizing NMR fragment-based drug screening for membrane protein targets
    Geoffrey Li, Manuel A. Castro, Thilini Ukwaththage, Charles R. Sanders · 2024 · Journal of Structural Biology X
  86. Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors
    Yue Wu, Zhensheng Jiang, Qidong You, Xiaojin Zhang · 2017 · Bioorganic & Medicinal Chemistry
  87. Privilegierte Strukturen neu betrachtet
    Petra Schneider, Gisbert Schneider · 2017 · Angewandte Chemie
  88. On the Implication of Water on Fragment‐to‐Ligand Growth in Kinase Binding Thermodynamics
    B. Wienen-Schmidt, Tobias Wulsdorf, Hendrik R. A. Jonker, Krishna Saxena, D. Kudlinzki, V.L. Linhard, Sridhar Sreeramulu, A. Heine, Harald Schwalbe, Gerhard Klebe · 2018 · ChemMedChem
  89. Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
    Kalyan Ghosh, Sk. Abdul Amin, Shovanlal Gayen, Tarun Jha · 2021 · Journal of Molecular Structure
  90. New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds
    Crescenzo Coppa, Luca Sorrentino, Monica Civera, Marco Minneci, Francesca Vasile, Sara Sattin · 2022 · Molecules
  91. Nuclear Receptor Chemical Reporter Enables Domain-Specific Analysis of Ligands in Mammalian Cells
    Taku Tsukidate, Qiang Li, Howard C. Hang · 2020 · ACS Chemical Biology
  92. ChemoDOTS: a web server to design chemistry-driven focused libraries
    Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, S. Betzi, Thomas W. Miller, Xavier Morelli, Philippe Roche · 2024 · Nucleic Acids Research
  93. Design and Synthesis of Novel β‐Carboline‐Bisindole Hybrids as Potential Anticancer Agents
    Nguyễn Thị Thanh Huyền, Ban Van Phuc, Tran Thi Huyen, Tran Thi Hong, Hien Nguyen, Van Ha Nguyen, Minh Tho Nguyen, Tran Quang Hung, Chau Phi Dinh, Tuan Thanh Dang · 2024 · ChemMedChem
  94. Strategy for cysteine-targeting covalent inhibitors screening using in-house database based LC-MS/MS and drug repurposing
    Xiaolan Hu, Jian‐Lin Wu, Quan He, Zhi‐Qi Xiong, Na Li · 2024 · Journal of Pharmaceutical Analysis
  95. Probing Protein–Ligand Methyl−π Interaction Geometries through Chemical Shift Measurements of Selectively Labeled Methyl Groups
    Andreas Beier, Gerald Platzer, Theresa Höfurthner, Aleksandra L. Ptaszek, Roman J. Lichtenecker, Leonhard Geist, Julian E. Fuchs, Darryl B. McConnell, Moriz Mayer, Robert Konrat · 2024 · Journal of Medicinal Chemistry
  96. E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion
    Omeir Khan, George S. Jones, Dima Kozakov, Dmitri Beglov, Diane Joseph‐McCarthy, Sándor Vajda · 2025 · Journal of Molecular Biology
  97. Combining MicroED and native mass spectrometry for structural discovery of enzyme–small molecule complexes
    Niko W. Vlahakis, Cameron W. Flowers, Mengting Liu, Matthew P. Agdanowski, Samuel E. Johnson, Jacob A. Summers, Lian M. C. Jacobs, Catherine Keyser, Phoebe Russell, Samuel L. Rose et al. · 2025 · Proceedings of the National Academy of Sciences
  98. Fragment-based and structure-guided discovery of perforin inhibitors
    Jiney Jose, Ruby H. P. Law, Eleanor W. W. Leung, Dorothy C.C. Wai, Hedieh Akhlaghi, Indu R. Chandrashekaran, Tom T. Caradoc-Davies, Ilia Voskoboinik, John T. Feutrill, David Middlemiss et al. · 2023 · European Journal of Medicinal Chemistry
  99. Current situation and the development of green pesticides in China
    Zhili Yuan, Wenwu Ye, YiPing HOU, Yuanchao Wang · 2023 · Scientia Sinica Vitae
  100. FBDD & De Novo Drug Design
    Anwesha Das, Arijit Nandi, Vijeta Kumari, Mallika Alvala · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks